Study of Testosterone and rHGH in FSHD
NCT03123913
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Facioscapulohumeral Muscular Dystrophy
Interventions
DRUG:
Testosterone Enanthate
DRUG:
Somatropin
Sponsor
University of Rochester